<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37893239</PMID><DateRevised><Year>2023</Year><Month>10</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9059</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>23</Day></PubDate></JournalIssue><Title>Biomedicines</Title><ISOAbbreviation>Biomedicines</ISOAbbreviation></Journal><ArticleTitle>Hierarchical Cluster Analysis Based on Clinical and Neuropsychological Symptoms Reveals Distinct Subgroups in Fibromyalgia: A Population-Based Cohort Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2867</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biomedicines11102867</ELocationID><Abstract><AbstractText>Fibromyalgia (FM) is a condition characterized by musculoskeletal pain and multiple comorbidities. Our study aimed to identify four clusters of FM patients according to their core clinical symptoms and neuropsychological comorbidities to identify possible therapeutic targets in the condition. We performed a population-based cohort study on 251 adult FM patients referred to primary care according to the 2010 ACR case criteria. Patients were aggregated in clusters by a K-medians hierarchical cluster analysis based on physical and emotional symptoms and neuropsychological variables. Four different clusters were identified in the FM population. Global cluster analysis reported a four-cluster profile (cluster 1: pain, fatigue, poorer sleep quality, stiffness, anxiety/depression and disability at work; cluster 2: injustice, catastrophizing, positive affect and negative affect; cluster 3: mindfulness and acceptance; and cluster 4: surrender). The second analysis on clinical symptoms revealed three distinct subgroups (cluster 1: fatigue, poorer sleep quality, stiffness and difficulties at work; cluster 2: pain; and cluster 3: anxiety and depression). The third analysis of neuropsychological variables provided two opposed subgroups (cluster 1: those with high scores in surrender, injustice, catastrophizing and negative affect, and cluster 2: those with high scores in acceptance, positive affect and mindfulness). These empirical results support models that assume an interaction between neurobiological, psychological and social factors beyond the classical biomedical model. A detailed assessment of such risk and protective factors is critical to differentiate FM subtypes, allowing for further identification of their specific needs and designing tailored personalized therapeutic interventions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Maurel</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, Universitat Aut&#xf2;noma de Barcelona, 08193 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gim&#xe9;nez-Llort</LastName><ForeName>Lydia</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-4091-489X</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry and Forensic Medicine, School of Medicine, Universitat Aut&#xf2;noma de Barcelona, 08193 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut de Neurosci&#xe8;ncies, Universitat Aut&#xf2;noma de Barcelona, 08193 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alegre-Martin</LastName><ForeName>Jose</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Clinical Unit in ME/CFS and Long COVID, Vall d'Hebron University Hospital, Universitat Aut&#xf2;noma de Barcelona, 08035 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Rheumatology, Research Unit in ME/CFS and Long COVID, Vall d'Hebron Research Institute, Universitat Aut&#xf2;noma de Barcelona, 08035 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castro-Marrero</LastName><ForeName>Jes&#xfa;s</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-2481-3052</Identifier><AffiliationInfo><Affiliation>Division of Rheumatology, Research Unit in ME/CFS and Long COVID, Vall d'Hebron Research Institute, Universitat Aut&#xf2;noma de Barcelona, 08035 Barcelona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomedicines</MedlineTA><NlmUniqueID>101691304</NlmUniqueID><ISSNLinking>2227-9059</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">chronic pain</Keyword><Keyword MajorTopicYN="N">cluster analysis</Keyword><Keyword MajorTopicYN="N">fatigue</Keyword><Keyword MajorTopicYN="N">fibromyalgia</Keyword><Keyword MajorTopicYN="N">mindfulness</Keyword><Keyword MajorTopicYN="N">neuropsychological symptoms</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study, in the collection, analyses or interpretation of data, in the writing of the manuscript or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>10</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>28</Day><Hour>11</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>28</Day><Hour>11</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>28</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37893239</ArticleId><ArticleId IdType="pmc">PMC10604090</ArticleId><ArticleId IdType="doi">10.3390/biomedicines11102867</ArticleId><ArticleId IdType="pii">biomedicines11102867</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nishishinya M.B., Rivera J., Alegre C., Pereda C.A. Non pharmacologic and alternative treatments in fibromyalgia. Med. Clin. 2006;127:295&#x2013;299. doi: 10.1016/s0025-7753(06)72237-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0025-7753(06)72237-0</ArticleId><ArticleId IdType="pubmed">16949015</ArticleId></ArticleIdList></Reference><Reference><Citation>Casanueva B., Garcia-Fructuoso F., Belenguer R., Alegre C., Moreno-Muelas J.V., Hernandez J.L., Pina T., Gonzalez-Gay M.A. The Spanish version of the 2010 American College of Rheumatology Preliminary Diagnostic Criteria for fibromyalgia: Reliability and validity assessment. Clin. Exp. Rheumatol. 2016;34:S55&#x2013;S58.</Citation><ArticleIdList><ArticleId IdType="pubmed">26752202</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold L.M. The pathophysiology, diagnosis and treatment of fibromyalgia. Psychiatr. Clin. N. Am. 2010;33:375&#x2013;408. doi: 10.1016/j.psc.2010.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psc.2010.01.001</ArticleId><ArticleId IdType="pubmed">20385343</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann L., Berzak A., Buskila D. Measuring health status in Israeli patients with fibromyalgia syndrome and widespread pain and healthy individuals: Utility of the short form 36-item health survey (SF-36) Semin. Arthritis Rheum. 2000;29:400&#x2013;408. doi: 10.1053/sarh.2000.7171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/sarh.2000.7171</ArticleId><ArticleId IdType="pubmed">10924026</ArticleId></ArticleIdList></Reference><Reference><Citation>Sansone R.A., Levengood J.V., Sellbom M. Psychological aspects of fibromyalgia: Research vs. clinician impressions. J. Psychosom. Res. 2004;56:185&#x2013;188. doi: 10.1016/S0022-3999(03)00063-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3999(03)00063-1</ArticleId><ArticleId IdType="pubmed">15016576</ArticleId></ArticleIdList></Reference><Reference><Citation>Dersh J., Polatin P.B., Gatchel R.J. Chronic pain and psychopathology: Research findings and theoretical considerations. Psychosom. Med. 2002;64:773&#x2013;786. doi: 10.1097/01.psy.0000024232.11538.54.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.psy.0000024232.11538.54</ArticleId><ArticleId IdType="pubmed">12271108</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatchel R.J., Peng Y.B., Peters M.L., Fuchs P.N., Turk D.C. The biopsychosocial approach to chronic pain: Scientific advances and future directions. Psychol. Bull. 2007;133:581&#x2013;624. doi: 10.1037/0033-2909.133.4.581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/0033-2909.133.4.581</ArticleId><ArticleId IdType="pubmed">17592957</ArticleId></ArticleIdList></Reference><Reference><Citation>Leadley R.M., Armstrong N., Lee Y.C., Allen A., Kleijnen J. Chronic diseases in the European Union: The prevalence and health cost implications of chronic pain. J. Pain. Palliat. Care Pharmacother. 2012;26:310&#x2013;325. doi: 10.3109/15360288.2012.736933.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/15360288.2012.736933</ArticleId><ArticleId IdType="pubmed">23216170</ArticleId></ArticleIdList></Reference><Reference><Citation>Munguia-Izquierdo D., Legaz-Arrese A. Determinants of sleep quality in middle-aged women with fibromyalgia syndrome. J. Sleep. Res. 2012;21:73&#x2013;79. doi: 10.1111/j.1365-2869.2011.00929.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2869.2011.00929.x</ArticleId><ArticleId IdType="pubmed">21615580</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashikar-Zuck S., Lynch A.M., Graham T.B., Swain N.F., Mullen S.M., Noll R.B. Social functioning and peer relationships of adolescents with juvenile fibromyalgia syndrome. Arthritis Rheum. 2007;57:474&#x2013;480. doi: 10.1002/art.22615.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.22615</ArticleId><ArticleId IdType="pubmed">17394218</ArticleId></ArticleIdList></Reference><Reference><Citation>Vittori A., Cascella M., Leonardi M., Monaco F., Nocerino D., Cuomo A., Ottaiano A., Perri F., Mascilini I., Francia E., et al. VOSviewer-Based Bibliometric Network Analysis for Evaluating Research on Juvenile Primary Fibromyalgia Syndrome (JPFS) Children. 2022;9:637. doi: 10.3390/children9050637.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/children9050637</ArticleId><ArticleId IdType="pmc">PMC9139718</ArticleId><ArticleId IdType="pubmed">35626815</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmona L., Ballina J., Gabriel R., Laffon A., Group E.S. The burden of musculoskeletal diseases in the general population of Spain: Results from a national survey. Ann. Rheum. Dis. 2001;60:1040&#x2013;1045. doi: 10.1136/ard.60.11.1040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.60.11.1040</ArticleId><ArticleId IdType="pmc">PMC1753418</ArticleId><ArticleId IdType="pubmed">11602475</ArticleId></ArticleIdList></Reference><Reference><Citation>Coles M.L., Uziel Y. Juvenile primary fibromyalgia syndrome: A Review- Treatment and Prognosis. Pediatr. Rheumatol. Online J. 2021;19:74. doi: 10.1186/s12969-021-00529-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12969-021-00529-x</ArticleId><ArticleId IdType="pmc">PMC8130260</ArticleId><ArticleId IdType="pubmed">34006290</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivera J., Alegre C., Nishishinya M.B., Pereda C.A. Evidencias terap&#xe9;uticas en fibromialgia. Reumatol. Clin. 2006;2((Suppl. 1)):S34&#x2013;S37. doi: 10.1016/S1699-258X(06)73080-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1699-258X(06)73080-7</ArticleId><ArticleId IdType="pubmed">21794360</ArticleId></ArticleIdList></Reference><Reference><Citation>Thieme K., Turk D.C., Flor H. Comorbid depression and anxiety in fibromyalgia syndrome: Relationship to somatic and psychosocial variables. Psychosom. Med. 2004;66:837&#x2013;844. doi: 10.1097/01.psy.0000146329.63158.40.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.psy.0000146329.63158.40</ArticleId><ArticleId IdType="pubmed">15564347</ArticleId></ArticleIdList></Reference><Reference><Citation>Price D.D., Staud R. Neurobiology of fibromyalgia syndrome. J. Rheumatol. Suppl. 2005;75:22&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">16078357</ArticleId></ArticleIdList></Reference><Reference><Citation>Crofford L.J. The relationship of fibromyalgia to neuropathic pain syndromes. J. Rheumatol. Suppl. 2005;75:41&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">16078360</ArticleId></ArticleIdList></Reference><Reference><Citation>Giesecke T., Williams D.A., Harris R.E., Cupps T.R., Tian X., Tian T.X., Gracely R.H., Clauw D.J. Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors. Arthritis Rheum. 2003;48:2916&#x2013;2922. doi: 10.1002/art.11272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.11272</ArticleId><ArticleId IdType="pubmed">14558098</ArticleId></ArticleIdList></Reference><Reference><Citation>Esteve-Vives J., Rivera Redondo J., Isabel Salvat Salvat M., de Gracia Blanco M., de Miquel C.A. Proposal for a consensus version of the Fibromyalgia Impact Questionnaire (FIQ) for the Spanish population. Reumatol. Clin. 2007;3:21&#x2013;24. doi: 10.1016/S1699-258X(07)73594-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1699-258X(07)73594-5</ArticleId><ArticleId IdType="pubmed">21794391</ArticleId></ArticleIdList></Reference><Reference><Citation>Burckhardt C.S., Clark S.R., Bennett R.M. The fibromyalgia impact questionnaire: Development and validation. J. Rheumatol. 1991;18:728&#x2013;733.</Citation><ArticleIdList><ArticleId IdType="pubmed">1865419</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrero M.J., Blanch J., Peri J.M., De Pablo J., Pintor L., Bulbena A. A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population. Gen. Hosp. Psychiatry. 2003;25:277&#x2013;283. doi: 10.1016/S0163-8343(03)00043-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0163-8343(03)00043-4</ArticleId><ArticleId IdType="pubmed">12850660</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodero B., Garcia-Campayo J., Casanueva B., del Hoyo Y.L., Serrano-Blanco A., Luciano J.V. Validation of the Spanish version of the Chronic Pain Acceptance Questionnaire (CPAQ) for the assessment of acceptance in fibromyalgia. Health Qual. Life Outcomes. 2010;8:37. doi: 10.1186/1477-7525-8-37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1477-7525-8-37</ArticleId><ArticleId IdType="pmc">PMC2876109</ArticleId><ArticleId IdType="pubmed">20385016</ArticleId></ArticleIdList></Reference><Reference><Citation>Soler J., Tejedor R., Feliu-Soler A., Pascual J.C., Cebolla A., Soriano J., Alvarez E., Perez V. Psychometric proprieties of Spanish version of Mindful Attention Awareness Scale (MAAS) Actas Esp. Psiquiatr. 2012;40:19&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">22344492</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson D., Clark L.A., Tellegen A. Development and validation of brief measures of positive and negative affect: The PANAS scales. J. Pers. Soc. Psychol. 1988;54:1063&#x2013;1070. doi: 10.1037/0022-3514.54.6.1063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/0022-3514.54.6.1063</ArticleId><ArticleId IdType="pubmed">3397865</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia Campayo J., Rodero B., Alda M., Sobradiel N., Montero J., Moreno S. Validation of the Spanish version of the Pain Catastrophizing Scale in fibromyalgia. Med. Clin. 2008;131:487&#x2013;492. doi: 10.1157/13127277.</Citation><ArticleIdList><ArticleId IdType="doi">10.1157/13127277</ArticleId><ArticleId IdType="pubmed">19007576</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Campayo J., Rodero B., del Hoyo Y.L., Luciano J.V., Alda M., Gili M. Validation of a Spanish language version of the pain self-perception scale in patients with fibromyalgia. BMC Musculoskelet. Disord. 2010;11:255. doi: 10.1186/1471-2474-11-255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2474-11-255</ArticleId><ArticleId IdType="pmc">PMC2991283</ArticleId><ArticleId IdType="pubmed">21050485</ArticleId></ArticleIdList></Reference><Reference><Citation>Wicksell R.K., Renofalt J., Olsson G.L., Bond F.W., Melin L. Avoidance and cognitive fusion--central components in pain related disability? Development and preliminary validation of the Psychological Inflexibility in Pain Scale (PIPS) Eur. J. Pain. 2008;12:491&#x2013;500. doi: 10.1016/j.ejpain.2007.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejpain.2007.08.003</ArticleId><ArticleId IdType="pubmed">17884643</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodero B., Luciano J.V., Montero-Marin J., Casanueva B., Palacin J.C., Gili M., Lopez del Hoyo Y., Serrano-Blanco A., Garcia-Campayo J. Perceived injustice in fibromyalgia: Psychometric characteristics of the Injustice Experience Questionnaire and relationship with pain catastrophising and pain acceptance. J. Psychosom. Res. 2012;73:86&#x2013;91. doi: 10.1016/j.jpsychores.2012.05.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2012.05.011</ArticleId><ArticleId IdType="pubmed">22789409</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan M.J., Adams H., Horan S., Maher D., Boland D., Gross R. The role of perceived injustice in the experience of chronic pain and disability: Scale development and validation. J. Occup. Rehabil. 2008;18:249&#x2013;261. doi: 10.1007/s10926-008-9140-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10926-008-9140-5</ArticleId><ArticleId IdType="pubmed">18536983</ArticleId></ArticleIdList></Reference><Reference><Citation>Belenguer R., Ramos-Casals M., Siso A., Rivera J. Classification of fibromyalgia. A systematic review of the literature. Reumatol. Clin. 2009;5:55&#x2013;62. doi: 10.1016/j.reuma.2008.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.reuma.2008.07.001</ArticleId><ArticleId IdType="pubmed">21794578</ArticleId></ArticleIdList></Reference><Reference><Citation>de Souza J.B., Goffaux P., Julien N., Potvin S., Charest J., Marchand S. Fibromyalgia subgroups: Profiling distinct subgroups using the Fibromyalgia Impact Questionnaire. A preliminary study. Rheumatol. Int. 2009;29:509&#x2013;515. doi: 10.1007/s00296-008-0722-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-008-0722-5</ArticleId><ArticleId IdType="pubmed">18820930</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller W., Schneider E.M., Stratz T. The classification of fibromyalgia syndrome. Rheumatol. Int. 2007;27:1005&#x2013;1010. doi: 10.1007/s00296-007-0403-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-007-0403-9</ArticleId><ArticleId IdType="pubmed">17653720</ArticleId></ArticleIdList></Reference><Reference><Citation>Turk D.C. The potential of treatment matching for subgroups of patients with chronic pain: Lumping versus splitting. Clin. J. Pain. 2005;21:44&#x2013;55; discussion 69&#x2013;72. doi: 10.1097/00002508-200501000-00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00002508-200501000-00006</ArticleId><ArticleId IdType="pubmed">15599131</ArticleId></ArticleIdList></Reference><Reference><Citation>de Miquel C.A., Campayo J., Florez M.T., Arguelles J.M., Tarrio E.B., Montoya M.G., Martin A., Salio A.M., Fuentes J.V., Alberch E.A., et al. Interdisciplinary consensus document for the treatment of fibromyalgia. Actas Esp. Psiquiatr. 2010;38:108&#x2013;120.</Citation><ArticleIdList><ArticleId IdType="pubmed">21361054</ArticleId></ArticleIdList></Reference><Reference><Citation>Porter-Moffitt S., Gatchel R.J., Robinson R.C., Deschner M., Posamentier M., Polatin P., Lou L. Biopsychosocial profiles of different pain diagnostic groups. J. Pain. 2006;7:308&#x2013;318. doi: 10.1016/j.jpain.2005.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpain.2005.12.003</ArticleId><ArticleId IdType="pubmed">16632320</ArticleId></ArticleIdList></Reference><Reference><Citation>Fietta P., Fietta P., Manganelli P. Fibromyalgia and psychiatric disorders. Acta Biomed. 2007;78:88&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">17933276</ArticleId></ArticleIdList></Reference><Reference><Citation>Epstein S.A., Kay G., Clauw D., Heaton R., Klein D., Krupp L., Kuck J., Leslie V., Masur D., Wagner M., et al. Psychiatric disorders in patients with fibromyalgia. A multicenter investigation. Psychosomatics. 1999;40:57&#x2013;63. doi: 10.1016/S0033-3182(99)71272-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0033-3182(99)71272-7</ArticleId><ArticleId IdType="pubmed">9989122</ArticleId></ArticleIdList></Reference><Reference><Citation>Rawlett K.E., Friedmann E., Thomas S.A. Mindfulness based intervention with an attentional comparison group in at risk young adolescents: A pilot randomized controlled trial. Integr. Med. Res. 2019;8:101&#x2013;106. doi: 10.1016/j.imr.2019.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imr.2019.04.002</ArticleId><ArticleId IdType="pmc">PMC6527909</ArticleId><ArticleId IdType="pubmed">31193363</ArticleId></ArticleIdList></Reference><Reference><Citation>Verra M.L., Angst F., Brioschi R., Lehmann S., Keefe F.J., Staal J.B., de Bie R.A., Aeschlimann A. Does classification of persons with fibromyalgia into Multidimensional Pain Inventory subgroups detect differences in outcome after a standard chronic pain management program? Pain. Res. Manag. 2009;14:445&#x2013;453. doi: 10.1155/2009/137901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2009/137901</ArticleId><ArticleId IdType="pmc">PMC2807772</ArticleId><ArticleId IdType="pubmed">20011715</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassett A.L., Simonelli L.E., Radvanski D.C., Buyske S., Savage S.V., Sigal L.H. The relationship between affect balance style and clinical outcomes in fibromyalgia. Arthritis Rheum. 2008;59:833&#x2013;840. doi: 10.1002/art.23708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.23708</ArticleId><ArticleId IdType="pubmed">18512724</ArticleId></ArticleIdList></Reference><Reference><Citation>Boersma K., Linton S.J. Screening to identify patients at risk: Profiles of psychological risk factors for early intervention. Clin. J. Pain. 2005;21:38&#x2013;43; discussion 69&#x2013;72. doi: 10.1097/00002508-200501000-00005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00002508-200501000-00005</ArticleId><ArticleId IdType="pubmed">15599130</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Zhao Y., Shone F., Li Z., Frangi A.F., Xie S.Q., Zhang Z.Q. Physics-informed Deep Learning for Musculoskeletal Modelling: Predicting Muscle Forces and Joint Kinematics from Surface EMG. IEEE Trans. Neural Syst. Rehabil. Eng. 2022;31:484&#x2013;493. doi: 10.1109/TNSRE.2022.3226860.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/TNSRE.2022.3226860</ArticleId><ArticleId IdType="pubmed">37015568</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Li Y., Xiao W., Zhang Z. Online Spatiotemporal Modeling for Robust and Lightweight Device-Free Lo-calization in Nonstationary Environments. IEEE Trans. Ind. Inform. 2023;19:8528&#x2013;8538. doi: 10.1109/TII.2022.3218666.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/TII.2022.3218666</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>